Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Hirao, Atsushi  [Clear All Filters]
2013
Yamada D, Hoshii T, Tanaka S, Hegazy AM, Kobayashi M, Tadokoro Y, Ohta K, Ueno M, Ali MAE, Hirao A. Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals. J Biochem. 2013.
2014
Ali MAE, Naka K, Yoshida A, Fuse K, Kasada A, Hoshii T, Tadokoro Y, Ueno M, Ohta K, Kobayashi M, et al. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients. Biochem Biophys Res Commun. 2014.
Hirao A. TPO signal for stem cell genomic integrity. Blood. 2014;123(4):459-60.
2015
Naka K, Ishihara K, Jomen Y, Jin CHua, Kim D-H, Gu Y-K, Jeong E-S, Li S, Krause DS, Kim D-W, et al. The novel oral TGF-β signaling inhibitor EW-7197 eradicates chronic myelogenous leukemia-initiating cells. Cancer Sci. 2015.
2018
Vu HThi, Kobayashi M, Hegazy AM, Tadokoro Y, Ueno M, Kasahara A, Takase Y, Nomura N, Peng H, Ito C, et al. Autophagy inhibition synergizes with calcium mobilization to achieve efficient therapy of malignant gliomas. Cancer Sci. 2018.
2020
Jiapaer S, Furuta T, Dong Y, Kitabayashi T, Sabit H, Zhang J, Zhang G, Tanaka S, Kobayashi M, Hirao A, et al. Identification of 2-fluoropalmitic acid as a potential therapeutic agent against glioblastoma. Curr Pharm Des. 2020.
2023
Nomura M, Ohuchi M, Sakamoto Y, Kudo K, Yaku K, Soga T, Sugiura Y, Morita M, Hayashi K, Miyahara S, et al. Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma. Nat Commun. 2023;14(1):8095.